Close Menu

NEW YORK (GenomeWeb) – South Korea's Macrogen announced recently that it received Good Clinical Laboratory Practice accreditation from that country's Ministry of Food and Drug Safety (MFDS.)

GCLP is a quality standard for labs that analyze blood and urine sample for clinical trials, Macrogen said. The designation will enable the firm to perform next-generation sequencing analyses on clinical trial samples. The firm said in a statement that it is the first and only lab in South Korea that is able to work with NGS on such samples.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
03

This webinar will provide an overview of how an international reference laboratory has implemented an automated next-generation sequencing workflow with custom panels for analyzing cancer samples.

Oct
24

This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.